Development of a Biologically Distinct EBV-Related Lymphoproliferative Disorder Following Autologous Bone Marrow Transplantation for an EBV-Negative Post-Renal Allograft Burkitt's Lymphoma

References

• Hanto D.W., Frizzera G., Gajl-Peczalska K.J., Simmons R.L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–472
   PubMed Web of Science ®Google Scholar
• Micallef T.N., Chhanabhai M., Gascoyne R.D., Shepherd J.D., Fung H.C., Nantel S.H., Toze C.L., Klingemann H.G., Sutherland H.J., Hogge D.E., Nevill T.J., Le A., Barnett M.J. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone Marrow Transplantation 1998; 22: 981–987
   PubMed Web of Science ®Google Scholar
• Gross T.G., Steinbuch M., DeFor T., Shapiro R.S., McGlave P., Ramsay N.K., Wagner J.E., Filipovich A.H. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplantation 1999; 23: 251–258
   PubMed Web of Science ®Google Scholar
• Birkeland S.A., Hamilton-Dutoit S., Sandvej K., Andersen H.M., Bendtzen K., Moller B., Jorgensen K.A. (1978) EBV-induced post-transplant lymphoproliferative disorder (PTLD). Transplantation Proceedings 1995; 27:3467–3472. 1995
   Google Scholar
• Niedobitek G., Mutimer D.J., Williams A., Whitehead L., Wilson P., Rooney N., Young L.S., Hubscher S.G. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients. International Journal of Cancer 1997; 73: 514–520
   PubMed Web of Science ®Google Scholar
• Hauke R.J., Greiner T.C., Smir B.N., Vose J.M., Tarantolo S.R., Bashir R.M., Bierman P.J. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplantation 1989; 21: 1271–1274
   Web of Science ®Google Scholar
• Chao N.J., Berry G.J., Advani R., Horning S.J., Weiss L.M., Blume K.G. Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation, SS: 1425–1428, [8] Briz M., Fores R., Regidor C., Busto M.J., Ramon y Cajal S., Cabrera R., Diez J.L., Sanjuan I. and Fernandez M.N. 1997 Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia. British Journal of Haematology 1993; 98:485-487. [9] Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson K.C., Ritz J., Shapiro R.S., Rickinson A. and Kieff E. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine; 321:1080-1085
   Google Scholar
• Shepherd J.D., Gascoyne R.D., Barnett M.J., Coghlan J.D., Phillips G.L. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplantation 1995; 15: 639–641
   PubMed Web of Science ®Google Scholar
• Peniket A.J., Perry A.R., Williams CD., MacMillan A., Watts M.J., Isaacson P.G., Goldstone A.H., Linch D.C. A case of EBV-associated lymphoproliferative disease following high- dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplantation 1998; 22: 307–309
   PubMed Web of Science ®Google Scholar
• Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Chhanabhai M., Adomat S.A., Gascoyne R.D., Horsman D.E. Clinical utility of heteroduplex analysis of TCR gamma gene rearrangements in the diagnosis of T-cell lymphoproliferative disorders. American Journal of Clinical Pathology 1997; 108: 295–301
   PubMed Web of Science ®Google Scholar
• Pedneault L., Katz B.Z. Comparison of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens. Journal of Medical Virology 1993; 39: 33–43
   PubMed Web of Science ®Google Scholar
• Swerdlow S.H. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Seminars in Diagnostic Pathology 1997; 14: 2–7
   PubMed Web of Science ®Google Scholar
• Hood I.M., Mahendra P., McNeil K., Marcus R.E. Hodgkin's disease after cardiac transplant: a report of two cases. Clinical and Laboratory Haematology 1996; 18: 115–116
   PubMedGoogle Scholar
• Liebowitz D. Epstein-Barr virus-an old dog with new tricks. New England Journal of Medicine 1995; 332: 55–57
   PubMed Web of Science ®Google Scholar
• Leblond V., Davi E, Charlotte F, Dorent R., Bitker M.O., Sutton L., Gandjbakhch I., Binet J.L., Raphael M. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?. Journal of Clinical Oncology 1998; 16: 2052–2059
   PubMed Web of Science ®Google Scholar
• Kingma D.W., Shad A., Tsokos M., Fest T., Otsuki T., Frekko K., Werner E., Werner A., Magrath I., Raffeld M., Jaffe E.S. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report. American Journal of Surgical Pathology 1996; 20: 1511–1519
   PubMed Web of Science ®Google Scholar
• Starzl T.E., Nalesnik M.A., Porter K.A., Ho M., Iwatsuki S., Griffith B.P., Rosenthal J.T., Hakala T.R., Shaw B.W., Hardesty R.L. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583–587
   PubMed Web of Science ®Google Scholar
• Faye A., Van Den Abeele T., Peuchmaur M., Mathieu-Boue A., Vilmer E. Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet 1998; 352: 1285
   PubMed Web of Science ®Google Scholar
• Benkerrou M., Jais J.P., Leblond V., Durandy A., Sutton L., Bordigoni P., Gamier J.L., Le Bidois J., Le Deist R, Blanche S., Fischer A. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 1998; 92: 3137–3147
   PubMed Web of Science ®Google Scholar
• O'Riordan J.M., Molloy K., O'Briain D.S., Corbally N., Devaney D., McShane D., Considine N., McCann S.R. Localized, late-onset, high-grade lymphoma following bone marrow transplantation: response to combination chemotherapy. British Journal of Haematology 1994; 86: 183–186
   PubMed Web of Science ®Google Scholar
• Rooney CM., Smith C.A., Ng C.Y., Loftin S., Li C., Krance R.A., Brenner M.K., Heslop H.E. Use of gene-modified virus-specific T lymphocytes to control Epstein- Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9–13
   PubMed Web of Science ®Google Scholar
• Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad E, Carabasi M.H., Castro-Malaspina H., Childs B.H., Gillio A.P., Small T.N. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow. New England Journal of Medicine 1986; 314: 729–735
   PubMed Web of Science ®Google Scholar
• Hanson M.N., Morrison V.A., Peterson B.A., Stieglbauer K.T., Kubic V.L., McCormick S.R., McGlennen R.C., Manivel J.C., Brunning R.D., Litz C.E. Posttransplant T-cell lymphoproliferative disorders-an aggressive, late complication of solid-organ transplantation. Blood 1996; 88: 3626–3633
   PubMed Web of Science ®Google Scholar